2801c Medicines infusion injection
Titre original de l'avis
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Score d'opportunité
Pourquoi ce score ?
Opportunité
35 / 100
Complexité
25 / 100
Facteurs de risque
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2030
- Procurement of various medicines for use in infusion injections
- Coverage for four regional health authorities: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF, Helse Nord RHF
Afficher le résumé complet
This tender by Sykehusinnkjøp HF, on behalf of the four Norwegian regional health authorities, seeks to procure various medicines for infusion injections. It is structured as a single-lot framework agreement for supplies, with an open procedure. The estimated value is not disclosed, and key details on award criteria, selection criteria, and required documents are missing from the notice. Submission is electronic via the provided URL, with a deadline of 17 September 2026.
Risques
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Contract as framework agreement
- Supplies nature
- EU funded (as per structured data, but XML notice indicates no EU funds - inconsistency)
Les exigences peuvent être incomplètes.
Acheteur
Localisation
VADSØ, NOR
Profil acheteur
Identifiant
916879067
Activité
Health
Lots (1)
LOT-0001
2801c Medicines infusion injection
Procurement of various medicines for use in infusion injections, covering the four regional health authorities in Norway. Framework agreement for supplies.
Localisation
Durée
Catégorie
Date limite
Détails des critères
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Description TED originale
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Détails de la procédure
- Date de publication
- 23 Jun 2026
- Langues
- English, Norwegian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 431517-2026
Documents (1)
Appels d'offres similaires
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Score d'opportunité
Pourquoi ce score ?
Opportunité
35 / 100
Complexité
25 / 100
Facteurs de risque
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications